LIM
RPTP

Longfellow Investment Management’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Longfellow Investment Management’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,054,678
Closed -$9.46M – 72
2016
Q3 		$9.46M Buy
+1,054,678
New +$7.5M 3.3% 15

Longfellow Investment Management's RPTP Position: Q4 2016 in Review

Longfellow Investment Management sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 1,054,678 shares — an estimated $9.46M sold.

Longfellow Investment Management first reported a position in RPTP in Q3 2016 and held it in 1 quarter. The position peaked at $9.46M in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Longfellow Investment Management reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Longfellow Investment Management sold 1,054,678 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $9.46M.
  • Longfellow Investment Management first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2016 and held it in 1 quarter.
  • Longfellow Investment Management's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $9.46M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Longfellow Investment Management's 13F filing for Q4 2016, filed 27 Jan 2017.